N4 Pharma Plc Share Price | |
---|---|
Price | 0.775 |
Bid | 0.75 |
Ask | 0.80 |
Change | -0.05 (-6.06%) |
Volume | 611,345 |
Open | 0.825 |
High | 0.825 |
Low | 0.775 |
Prev. Close | 0.825 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 268.78m |
Market Capitalisation | £2.08m |
Market Size | 50,000 |
52 Week High | 2.10 |
52 Week High Date | 02-May-2023 |
52 Week Low | 0.625 |
52 Week Low Date | 28-Mar-2024 |
# Trades | 14 |
---|---|
Vol. Sold | 595,448 |
Sold Value | £4.56k |
Vol. Bought | 15,897 |
Bought Value | £N/A |
PE Ratio | -1.490385 |
Earnings | -0.52 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
26-Apr-24 | 16:18:04 | 0.80 | 500 | Buy* | 0.75 | 0.80 | 4.00 | O Ordinary |
26-Apr-24 | 15:32:39 | 0.768 | 90,000 | Sell* | 0.75 | 0.85 | 691.20 | O Ordinary |
26-Apr-24 | 15:22:33 | 0.765 | 2,476 | Sell* | 0.75 | 0.85 | 18.94 | O Ordinary |
26-Apr-24 | 15:03:49 | 0.765 | 200 | Sell* | 0.75 | 0.85 | 1.53 | O Ordinary |
26-Apr-24 | 14:48:09 | 0.75 | 1,550 | Sell* | 0.75 | 0.85 | 11.63 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 13:40:46 | 0.85 | 117 | Buy* | 0.75 | 0.85 | 0.99 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 13:40:46 | 0.85 | 5,000 | Buy* | 0.75 | 0.85 | 42.50 | O Ordinary Trade was executed as an SI |
26-Apr-24 | 13:09:44 | 0.825 | 10,000 | Buy* | 0.75 | 0.85 | 82.50 | O Ordinary |
26-Apr-24 | 10:40:40 | 0.765 | 1,000 | Sell* | 0.75 | 0.85 | 7.65 | O Ordinary |
26-Apr-24 | 10:36:51 | 0.765 | 250,000 | Sell* | 0.75 | 0.85 | 1,913 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
10-Apr-19 | 10-Apr-19 | Buy | Nigel Theobald held the position of CEO at the time of this trade.Nigel Theobald | 44.40 | GBX | 67,343 | 12,389,919 |
10-Apr-19 | 10-Apr-19 | Buy | Nigel Theobald held the position of CEO at the time of this trade.Nigel Theobald | 4.44 | GBX | 67,343 | 12,389,919 |
10-Nov-17 | 10-Nov-17 | Buy | Nigel Theobald held the position of CEO at the time of this trade.Nigel Theobald | 7.92 | GBX | 56,656 | 12,255,233 |